Name: Genistein & Daidzein
Brand: Nova Science Publishers, Inc
SKU: 9781634831949
Price: 158.59 GBP
Availability: InStock

Genistein & Daidzein

Food Sources, Biological Activity & Health Benefits

Edited by: Masayoshi Yamaguchi

Published by Nova Science Publishers, Inc

In Stock

£243.99

£158.59

Published: 01-Sep-2015
ISBN: 9781634831949

Hardback
193 Pages

Subjects:
Dietetics & nutrition

Quantity

Soybeans are greatly used in many foods, such as tofu, soy milk and yogurt, and it plays an important role as a functional food in the health and prevention of various diseases. Soybeans contain rich isoflavones including genistein, daidzein and glycitein, and both genistein and daidzein occur at higher concentrations. Isoflavones are structurally and functionally similar to 17ßestradiol. Isoflavones are found to bind to estrogen receptors and the peroxisome proliferator-activated receptor (PPAR) family and aryl hydrocarbon receptors. Moreover, isoflavones affect activity of tyrosine kinases, histones, transcription factors, adenosine mono phosphate pathways, RNA expression and other intracellular regulators. Thus, isoflavones play a multifunctional role in cell regulation. This book focuses on recent advances in the food sources, biological activity and health benefits of genistein and daizen.

Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Adjunct Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA (2013 - ). Dr. Yamaguchi is engaged in the fields of endocrinology and cell signaling since 1971, and these researches are developed in the aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetes and diabetic osteoporosis, cancer biology, and cancer cell bone metastasis. Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001). Dr Yamaguchi generated regucalcin transgenic rats, which were registered as international patents including USA, EU and Japan, and this animal was found to induce osteoporosis and hyperlipidemia. Moreover, Dr. Yamaguchi proposed the potential role of regucalcin as a key suppressor protein in carcinogenesis. Thus far, Dr Yamaguchi published over 550 English articles to professional journals with peer-review, and registered over 20 national and international patents.